Since search engines have prioritized websites that are mobile friendly, there have been ongoing efforts by marketing companies to ensure that their clients’ websites are viewable on all devices. To maintain said efforts, fishbat discusses the importance of a...
Advances Second Late Stage Program for ADAM Microneedle Technology FREMONT, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) — Zosano Pharma Corporation (ZSAN), a clinical-stage biopharmaceutical company, today announced that the company has begun enrolling cluster...
– Generalized anxiety disorder impacts approximately 7 million U.S. adults annually and many do not fully respond to current therapies – Troriluzole is a new chemical entity that modulates glutamate in an effort to reduce the severity of anxiety, worry and...
Replimune’s second product candidate to enter the clinic is an Immulytic™ that expresses an anti-CTLA-4 antibody-like protein WOBURN, Mass., Oct. 24, 2019 (GLOBE NEWSWIRE) — Replimune Group Inc. (REPL), a biotechnology company developing oncolytic immuno-gene...
MCY-M11 is being evaluated in relapsed/refractory ovarian cancer and peritoneal mesothelioma CARMA platform offers faster manufacturing speeds, broader therapeutic applications, combination opportunities and repeat dosing potential GAITHERSBURG, Md., Oct. 24,...
WALTHAM, Mass., Oct. 25, 2019 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (AMAG) today announced that the results of PROLONG (Progestin’s Role in Optimizing Neonatal Gestation) were published online in the American Journal of Perinatology. PROLONG was a...
Email
Text